These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1273711)

  • 1. Isoniazid inactivation in Black patients with tuberculosis.
    Buchanan N; Strickwold B; Shuenyane E
    S Afr Med J; 1976 Mar; 50(12):463-5. PubMed ID: 1273711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid acetylator status of Black South African tuberculosis patients.
    Bach PH; Higgins-Opitz SB; Bima B; Leary WP
    S Afr Med J; 1976 Jul; 50(29):1132-4. PubMed ID: 959925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
    Bouayad Z; Chevalier B; Maurin R; Bartal M
    Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of various isoniazid slow releasing matrix preparations for intermittent chemotherapy of tuberculosis.
    Hodgkin MM; Eidus L; Hershfield ES
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):349-65. PubMed ID: 461989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for determining acetylator phenotype using isoniazid.
    Hutchings A; Routledge PA
    Br J Clin Pharmacol; 1986 Sep; 22(3):343-5. PubMed ID: 3768246
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
    Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.
    Jing W; Zong Z; Tang B; Wang J; Zhang T; Wen S; Xue Y; Chu N; Zhao W; Huang H
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.
    Cordes H; Thiel C; Aschmann HE; Baier V; Blank LM; Kuepfer L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6134-45. PubMed ID: 27480867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid levels in black patients dosed with a matrix preparation (Tebesium).
    Glatthaar E; Gärtig D; Stander MF; Kleeberg HH
    Prax Klin Pneumol; 1977 Oct; 31(10):855-9. PubMed ID: 928288
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping of South African black tuberculosis patients for inactivation of isoniazid.
    Eidus L; Glatthaar E; Hodgkin MM; Nel EE; Kleeberg HH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):243-56. PubMed ID: 461951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.
    Singh N; Dubey S; Chinnaraj S; Golani A; Maitra A
    Mol Diagn Ther; 2009; 13(1):49-58. PubMed ID: 19351215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid pharmacokinetics in children according to acetylator phenotype.
    Rey E; Gendrel D; Treluyer JM; Tran A; Pariente-Khayat A; d'Athis P; Pons G
    Fundam Clin Pharmacol; 2001 Oct; 15(5):355-9. PubMed ID: 11903505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of determining plasma INH during antitubercular treatment. Retrospective analysis of 204 cases].
    Cheminat JC; Paire M; Lavarenne J; Ducarrouge C; Molina C
    Rev Fr Mal Respir; 1983; 11(6):867-73. PubMed ID: 6669797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status.
    Eriksson M; Bolme P; Habte D; Paalzow L
    Acta Paediatr Scand; 1988 Nov; 77(6):890-4. PubMed ID: 3144828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of isoniazid in patients with tuberculosis (author's transl)].
    Meier N; Pierart O; Kuhn S; Zabala M; Woywood E; Abarca L; Cortés S
    Rev Med Chil; 1977 Jun; 105(6):390-2. PubMed ID: 897430
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of blood proteins in binding and inactivation of HINA].
    Dudchik GKh; bilyk MA
    Probl Tuberk; 1976; 3():52-5. PubMed ID: 967859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.